Bhavneet Bhinder

11PUBLICATIONS
162CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 26, 2026
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.

|Apr 29, 2026
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.

|Feb 24, 2026
MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphoma.

Jia Ruan, David A Bond, Bijal Shah

|Nov 25, 2025
MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphoma.

Jia Ruan, David A Bond, Bijal Shah

|Oct 02, 2025
Epigenetic Regulation of Chromosomal Instability by EZH2 Methyltransferase.

Yang Bai, Albert S Agustinus, Shira Yomtoubian

|Mar 03, 2025
Simultaneous immunomodulation and epithelial-to-mesenchymal transition drives lung adenocarcinoma progression.

Junbum Kim, Hiranmayi Ravichandran, Liron Yoffe

Pageof 2

Frequent Collaborators

9 joint publications

Olivier Elemento

4 joint publications

Michael Sigouros

4 joint publications

Manik Uppal

3 joint publications

Kenneth Wha Eng